nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP2D6—Vinorelbine—ovarian cancer	0.104	0.255	CbGbCtD
Ciclesonide—CYP3A4—Topotecan—ovarian cancer	0.0942	0.23	CbGbCtD
Ciclesonide—CYP3A4—Vinorelbine—ovarian cancer	0.0664	0.162	CbGbCtD
Ciclesonide—CYP3A4—Paclitaxel—ovarian cancer	0.0467	0.114	CbGbCtD
Ciclesonide—CYP2D6—Doxorubicin—ovarian cancer	0.0395	0.0964	CbGbCtD
Ciclesonide—CYP3A4—Docetaxel—ovarian cancer	0.0337	0.0822	CbGbCtD
Ciclesonide—SERPINA6—oviduct—ovarian cancer	0.0271	0.285	CbGeAlD
Ciclesonide—CYP3A4—Doxorubicin—ovarian cancer	0.0251	0.0613	CbGbCtD
Ciclesonide—CES1—female reproductive system—ovarian cancer	0.00505	0.0533	CbGeAlD
Ciclesonide—SERPINA6—female reproductive system—ovarian cancer	0.00505	0.0532	CbGeAlD
Ciclesonide—SERPINA6—bone marrow—ovarian cancer	0.00476	0.0502	CbGeAlD
Ciclesonide—CES1—female gonad—ovarian cancer	0.0046	0.0485	CbGeAlD
Ciclesonide—CES1—testis—ovarian cancer	0.00408	0.043	CbGeAlD
Ciclesonide—NR3C1—myometrium—ovarian cancer	0.00379	0.04	CbGeAlD
Ciclesonide—NR3C1—embryo—ovarian cancer	0.00365	0.0384	CbGeAlD
Ciclesonide—NR3C1—epithelium—ovarian cancer	0.00298	0.0314	CbGeAlD
Ciclesonide—CES1—lymph node—ovarian cancer	0.00296	0.0312	CbGeAlD
Ciclesonide—NR3C1—uterine cervix—ovarian cancer	0.00295	0.0311	CbGeAlD
Ciclesonide—NR3C1—decidua—ovarian cancer	0.00281	0.0296	CbGeAlD
Ciclesonide—NR3C1—endometrium—ovarian cancer	0.00267	0.0281	CbGeAlD
Ciclesonide—Oral candidiasis—Epirubicin—ovarian cancer	0.00267	0.00539	CcSEcCtD
Ciclesonide—Haemoglobin—Topotecan—ovarian cancer	0.0026	0.00525	CcSEcCtD
Ciclesonide—Rhinitis—Topotecan—ovarian cancer	0.00259	0.00524	CcSEcCtD
Ciclesonide—Haemorrhage—Topotecan—ovarian cancer	0.00259	0.00523	CcSEcCtD
Ciclesonide—Pharyngitis—Topotecan—ovarian cancer	0.00257	0.00519	CcSEcCtD
Ciclesonide—Haemoglobin—Melphalan—ovarian cancer	0.00255	0.00514	CcSEcCtD
Ciclesonide—Haemorrhage—Melphalan—ovarian cancer	0.00253	0.00512	CcSEcCtD
Ciclesonide—Ear pain—Paclitaxel—ovarian cancer	0.00252	0.0051	CcSEcCtD
Ciclesonide—Pneumonia—Vinorelbine—ovarian cancer	0.00248	0.00501	CcSEcCtD
Ciclesonide—NR3C1—gonad—ovarian cancer	0.00248	0.0261	CbGeAlD
Ciclesonide—Oral candidiasis—Doxorubicin—ovarian cancer	0.00247	0.00499	CcSEcCtD
Ciclesonide—Infestation—Vinorelbine—ovarian cancer	0.00247	0.00498	CcSEcCtD
Ciclesonide—Infestation NOS—Vinorelbine—ovarian cancer	0.00247	0.00498	CcSEcCtD
Ciclesonide—NR3C1—uterus—ovarian cancer	0.00246	0.0259	CbGeAlD
Ciclesonide—Swelling—Paclitaxel—ovarian cancer	0.00244	0.00493	CcSEcCtD
Ciclesonide—Candida infection—Docetaxel—ovarian cancer	0.0024	0.00485	CcSEcCtD
Ciclesonide—Nasal congestion—Paclitaxel—ovarian cancer	0.00236	0.00477	CcSEcCtD
Ciclesonide—Immune system disorder—Topotecan—ovarian cancer	0.00234	0.00472	CcSEcCtD
Ciclesonide—Mediastinal disorder—Topotecan—ovarian cancer	0.00233	0.00471	CcSEcCtD
Ciclesonide—Angioedema—Chlorambucil—ovarian cancer	0.00231	0.00467	CcSEcCtD
Ciclesonide—Immune system disorder—Melphalan—ovarian cancer	0.00229	0.00462	CcSEcCtD
Ciclesonide—Mediastinal disorder—Melphalan—ovarian cancer	0.00228	0.00461	CcSEcCtD
Ciclesonide—NR3C1—female reproductive system—ovarian cancer	0.00221	0.0233	CbGeAlD
Ciclesonide—Back pain—Topotecan—ovarian cancer	0.00218	0.0044	CcSEcCtD
Ciclesonide—Pain in extremity—Paclitaxel—ovarian cancer	0.00215	0.00435	CcSEcCtD
Ciclesonide—NR3C1—bone marrow—ovarian cancer	0.00209	0.022	CbGeAlD
Ciclesonide—Swelling—Docetaxel—ovarian cancer	0.00207	0.00418	CcSEcCtD
Ciclesonide—Dysphonia—Epirubicin—ovarian cancer	0.00206	0.00416	CcSEcCtD
Ciclesonide—Angioedema—Topotecan—ovarian cancer	0.00206	0.00416	CcSEcCtD
Ciclesonide—Infection—Chlorambucil—ovarian cancer	0.00205	0.00414	CcSEcCtD
Ciclesonide—NR3C1—female gonad—ovarian cancer	0.00201	0.0212	CbGeAlD
Ciclesonide—Immune system disorder—Vinorelbine—ovarian cancer	0.002	0.00404	CcSEcCtD
Ciclesonide—NR3C1—vagina—ovarian cancer	0.002	0.0211	CbGeAlD
Ciclesonide—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00199	0.00403	CcSEcCtD
Ciclesonide—Cough—Topotecan—ovarian cancer	0.00197	0.00397	CcSEcCtD
Ciclesonide—Cough—Melphalan—ovarian cancer	0.00192	0.00389	CcSEcCtD
Ciclesonide—Nasopharyngitis—Paclitaxel—ovarian cancer	0.00192	0.00389	CcSEcCtD
Ciclesonide—Arthralgia—Topotecan—ovarian cancer	0.00192	0.00387	CcSEcCtD
Ciclesonide—Chest pain—Topotecan—ovarian cancer	0.00192	0.00387	CcSEcCtD
Ciclesonide—Dysphonia—Doxorubicin—ovarian cancer	0.00191	0.00385	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.0019	0.00383	CcSEcCtD
Ciclesonide—Chest pain—Melphalan—ovarian cancer	0.00188	0.00379	CcSEcCtD
Ciclesonide—Back pain—Vinorelbine—ovarian cancer	0.00186	0.00377	CcSEcCtD
Ciclesonide—Influenza—Paclitaxel—ovarian cancer	0.00186	0.00376	CcSEcCtD
Ciclesonide—Infection—Topotecan—ovarian cancer	0.00183	0.00369	CcSEcCtD
Ciclesonide—Pain in extremity—Docetaxel—ovarian cancer	0.00182	0.00369	CcSEcCtD
Ciclesonide—Dyspepsia—Chlorambucil—ovarian cancer	0.00182	0.00367	CcSEcCtD
Ciclesonide—Ulcer—Epirubicin—ovarian cancer	0.00179	0.00362	CcSEcCtD
Ciclesonide—Bronchitis—Paclitaxel—ovarian cancer	0.00179	0.00361	CcSEcCtD
Ciclesonide—Infection—Melphalan—ovarian cancer	0.00179	0.00361	CcSEcCtD
Ciclesonide—NR3C1—testis—ovarian cancer	0.00178	0.0188	CbGeAlD
Ciclesonide—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00178	0.0036	CcSEcCtD
Ciclesonide—Fatigue—Chlorambucil—ovarian cancer	0.00178	0.0036	CcSEcCtD
Ciclesonide—Angioedema—Vinorelbine—ovarian cancer	0.00176	0.00356	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.00173	0.00349	CcSEcCtD
Ciclesonide—Palpitations—Vinorelbine—ovarian cancer	0.0017	0.00344	CcSEcCtD
Ciclesonide—Weight increased—Paclitaxel—ovarian cancer	0.00169	0.00342	CcSEcCtD
Ciclesonide—Cough—Vinorelbine—ovarian cancer	0.00168	0.0034	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00167	0.00338	CcSEcCtD
Ciclesonide—CYP3A4—female reproductive system—ovarian cancer	0.00167	0.0176	CbGeAlD
Ciclesonide—Pneumonia—Paclitaxel—ovarian cancer	0.00167	0.00337	CcSEcCtD
Ciclesonide—Hypertension—Vinorelbine—ovarian cancer	0.00166	0.00336	CcSEcCtD
Ciclesonide—Infestation—Paclitaxel—ovarian cancer	0.00166	0.00335	CcSEcCtD
Ciclesonide—Infestation NOS—Paclitaxel—ovarian cancer	0.00166	0.00335	CcSEcCtD
Ciclesonide—Ulcer—Doxorubicin—ovarian cancer	0.00166	0.00335	CcSEcCtD
Ciclesonide—CYP2D6—female reproductive system—ovarian cancer	0.00165	0.0173	CbGeAlD
Ciclesonide—Urticaria—Chlorambucil—ovarian cancer	0.00164	0.00331	CcSEcCtD
Ciclesonide—Arthralgia—Vinorelbine—ovarian cancer	0.00164	0.00331	CcSEcCtD
Ciclesonide—Chest pain—Vinorelbine—ovarian cancer	0.00164	0.00331	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00164	0.00331	CcSEcCtD
Ciclesonide—Dyspnoea—Topotecan—ovarian cancer	0.00164	0.00331	CcSEcCtD
Ciclesonide—Nasopharyngitis—Docetaxel—ovarian cancer	0.00163	0.0033	CcSEcCtD
Ciclesonide—Candida infection—Epirubicin—ovarian cancer	0.00162	0.00327	CcSEcCtD
Ciclesonide—Dyspepsia—Topotecan—ovarian cancer	0.00162	0.00327	CcSEcCtD
Ciclesonide—Conjunctivitis—Paclitaxel—ovarian cancer	0.00161	0.00326	CcSEcCtD
Ciclesonide—Urinary tract infection—Paclitaxel—ovarian cancer	0.00161	0.00326	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.00161	0.00325	CcSEcCtD
Ciclesonide—Dyspnoea—Melphalan—ovarian cancer	0.0016	0.00324	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00159	0.00321	CcSEcCtD
Ciclesonide—Fatigue—Topotecan—ovarian cancer	0.00158	0.0032	CcSEcCtD
Ciclesonide—Dyspepsia—Melphalan—ovarian cancer	0.00158	0.0032	CcSEcCtD
Ciclesonide—Epistaxis—Paclitaxel—ovarian cancer	0.00156	0.00316	CcSEcCtD
Ciclesonide—Infection—Vinorelbine—ovarian cancer	0.00156	0.00316	CcSEcCtD
Ciclesonide—Sinusitis—Paclitaxel—ovarian cancer	0.00156	0.00314	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00155	0.00314	CcSEcCtD
Ciclesonide—Fatigue—Melphalan—ovarian cancer	0.00155	0.00314	CcSEcCtD
Ciclesonide—Bronchospasm—Docetaxel—ovarian cancer	0.00155	0.00313	CcSEcCtD
Ciclesonide—Candida infection—Doxorubicin—ovarian cancer	0.0015	0.00303	CcSEcCtD
Ciclesonide—CYP2D6—female gonad—ovarian cancer	0.0015	0.0158	CbGeAlD
Ciclesonide—Haemoglobin—Paclitaxel—ovarian cancer	0.0015	0.00302	CcSEcCtD
Ciclesonide—Rhinitis—Paclitaxel—ovarian cancer	0.00149	0.00302	CcSEcCtD
Ciclesonide—Haemorrhage—Paclitaxel—ovarian cancer	0.00149	0.00301	CcSEcCtD
Ciclesonide—Asthenia—Chlorambucil—ovarian cancer	0.00148	0.00299	CcSEcCtD
Ciclesonide—Pharyngitis—Paclitaxel—ovarian cancer	0.00148	0.00299	CcSEcCtD
Ciclesonide—Urticaria—Topotecan—ovarian cancer	0.00146	0.00295	CcSEcCtD
Ciclesonide—Weight increased—Docetaxel—ovarian cancer	0.00143	0.0029	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00143	0.00289	CcSEcCtD
Ciclesonide—Urticaria—Melphalan—ovarian cancer	0.00143	0.00289	CcSEcCtD
Ciclesonide—Diabetes mellitus—Epirubicin—ovarian cancer	0.00141	0.00286	CcSEcCtD
Ciclesonide—Pneumonia—Docetaxel—ovarian cancer	0.00141	0.00286	CcSEcCtD
Ciclesonide—Infestation NOS—Docetaxel—ovarian cancer	0.00141	0.00284	CcSEcCtD
Ciclesonide—Infestation—Docetaxel—ovarian cancer	0.00141	0.00284	CcSEcCtD
Ciclesonide—Dyspnoea—Vinorelbine—ovarian cancer	0.0014	0.00283	CcSEcCtD
Ciclesonide—Conjunctivitis—Docetaxel—ovarian cancer	0.00137	0.00276	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00136	0.00274	CcSEcCtD
Ciclesonide—Fatigue—Vinorelbine—ovarian cancer	0.00136	0.00274	CcSEcCtD
Ciclesonide—Immune system disorder—Paclitaxel—ovarian cancer	0.00134	0.00272	CcSEcCtD
Ciclesonide—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00134	0.00271	CcSEcCtD
Ciclesonide—CYP2D6—testis—ovarian cancer	0.00133	0.014	CbGeAlD
Ciclesonide—Epistaxis—Docetaxel—ovarian cancer	0.00133	0.00268	CcSEcCtD
Ciclesonide—Asthenia—Topotecan—ovarian cancer	0.00132	0.00266	CcSEcCtD
Ciclesonide—Diabetes mellitus—Doxorubicin—ovarian cancer	0.00131	0.00264	CcSEcCtD
Ciclesonide—NR3C1—lymph node—ovarian cancer	0.00129	0.0136	CbGeAlD
Ciclesonide—Asthenia—Melphalan—ovarian cancer	0.00129	0.00261	CcSEcCtD
Ciclesonide—Dysgeusia—Paclitaxel—ovarian cancer	0.00127	0.00256	CcSEcCtD
Ciclesonide—Haemoglobin—Docetaxel—ovarian cancer	0.00127	0.00256	CcSEcCtD
Ciclesonide—Rhinitis—Docetaxel—ovarian cancer	0.00127	0.00256	CcSEcCtD
Ciclesonide—Haemorrhage—Docetaxel—ovarian cancer	0.00126	0.00255	CcSEcCtD
Ciclesonide—Back pain—Paclitaxel—ovarian cancer	0.00125	0.00253	CcSEcCtD
Ciclesonide—Pharyngitis—Docetaxel—ovarian cancer	0.00125	0.00253	CcSEcCtD
Ciclesonide—Urticaria—Vinorelbine—ovarian cancer	0.00125	0.00252	CcSEcCtD
Ciclesonide—Pain in extremity—Epirubicin—ovarian cancer	0.00123	0.00249	CcSEcCtD
Ciclesonide—Nausea—Chlorambucil—ovarian cancer	0.00123	0.00248	CcSEcCtD
Ciclesonide—Dizziness—Topotecan—ovarian cancer	0.00122	0.00246	CcSEcCtD
Ciclesonide—Face oedema—Epirubicin—ovarian cancer	0.00119	0.0024	CcSEcCtD
Ciclesonide—Angioedema—Paclitaxel—ovarian cancer	0.00118	0.00239	CcSEcCtD
Ciclesonide—Rash—Topotecan—ovarian cancer	0.00116	0.00234	CcSEcCtD
Ciclesonide—Dermatitis—Topotecan—ovarian cancer	0.00116	0.00234	CcSEcCtD
Ciclesonide—Headache—Topotecan—ovarian cancer	0.00115	0.00233	CcSEcCtD
Ciclesonide—Palpitations—Paclitaxel—ovarian cancer	0.00115	0.00231	CcSEcCtD
Ciclesonide—Immune system disorder—Docetaxel—ovarian cancer	0.00114	0.0023	CcSEcCtD
Ciclesonide—Pain in extremity—Doxorubicin—ovarian cancer	0.00114	0.0023	CcSEcCtD
Ciclesonide—Mediastinal disorder—Docetaxel—ovarian cancer	0.00114	0.0023	CcSEcCtD
Ciclesonide—Rash—Melphalan—ovarian cancer	0.00113	0.00229	CcSEcCtD
Ciclesonide—Dermatitis—Melphalan—ovarian cancer	0.00113	0.00229	CcSEcCtD
Ciclesonide—Cough—Paclitaxel—ovarian cancer	0.00113	0.00228	CcSEcCtD
Ciclesonide—Asthenia—Vinorelbine—ovarian cancer	0.00113	0.00228	CcSEcCtD
Ciclesonide—Hypertension—Paclitaxel—ovarian cancer	0.00112	0.00226	CcSEcCtD
Ciclesonide—Arthralgia—Paclitaxel—ovarian cancer	0.0011	0.00223	CcSEcCtD
Ciclesonide—Chest pain—Paclitaxel—ovarian cancer	0.0011	0.00223	CcSEcCtD
Ciclesonide—Nasopharyngitis—Epirubicin—ovarian cancer	0.0011	0.00222	CcSEcCtD
Ciclesonide—Face oedema—Doxorubicin—ovarian cancer	0.0011	0.00222	CcSEcCtD
Ciclesonide—Nausea—Topotecan—ovarian cancer	0.00109	0.00221	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00109	0.00219	CcSEcCtD
Ciclesonide—Dry mouth—Paclitaxel—ovarian cancer	0.00108	0.00218	CcSEcCtD
Ciclesonide—Dysgeusia—Docetaxel—ovarian cancer	0.00108	0.00217	CcSEcCtD
Ciclesonide—Nausea—Melphalan—ovarian cancer	0.00107	0.00216	CcSEcCtD
Ciclesonide—Influenza—Epirubicin—ovarian cancer	0.00106	0.00215	CcSEcCtD
Ciclesonide—Back pain—Docetaxel—ovarian cancer	0.00106	0.00215	CcSEcCtD
Ciclesonide—Infection—Paclitaxel—ovarian cancer	0.00105	0.00212	CcSEcCtD
Ciclesonide—Dizziness—Vinorelbine—ovarian cancer	0.00104	0.0021	CcSEcCtD
Ciclesonide—Bronchitis—Epirubicin—ovarian cancer	0.00102	0.00207	CcSEcCtD
Ciclesonide—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00102	0.00206	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.001	0.00203	CcSEcCtD
Ciclesonide—Rash—Vinorelbine—ovarian cancer	0.000992	0.002	CcSEcCtD
Ciclesonide—Dermatitis—Vinorelbine—ovarian cancer	0.000991	0.002	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000988	0.002	CcSEcCtD
Ciclesonide—Headache—Vinorelbine—ovarian cancer	0.000985	0.00199	CcSEcCtD
Ciclesonide—Influenza—Doxorubicin—ovarian cancer	0.000984	0.00199	CcSEcCtD
Ciclesonide—Palpitations—Docetaxel—ovarian cancer	0.000971	0.00196	CcSEcCtD
Ciclesonide—Weight increased—Epirubicin—ovarian cancer	0.000968	0.00196	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000964	0.00195	CcSEcCtD
Ciclesonide—Cough—Docetaxel—ovarian cancer	0.000959	0.00194	CcSEcCtD
Ciclesonide—Pneumonia—Epirubicin—ovarian cancer	0.000954	0.00193	CcSEcCtD
Ciclesonide—Hypertension—Docetaxel—ovarian cancer	0.000948	0.00192	CcSEcCtD
Ciclesonide—Infestation NOS—Epirubicin—ovarian cancer	0.000948	0.00192	CcSEcCtD
Ciclesonide—Infestation—Epirubicin—ovarian cancer	0.000948	0.00192	CcSEcCtD
Ciclesonide—Bronchitis—Doxorubicin—ovarian cancer	0.000946	0.00191	CcSEcCtD
Ciclesonide—Dyspnoea—Paclitaxel—ovarian cancer	0.000943	0.00191	CcSEcCtD
Ciclesonide—Arthralgia—Docetaxel—ovarian cancer	0.000935	0.00189	CcSEcCtD
Ciclesonide—Chest pain—Docetaxel—ovarian cancer	0.000935	0.00189	CcSEcCtD
Ciclesonide—Nausea—Vinorelbine—ovarian cancer	0.000934	0.00189	CcSEcCtD
Ciclesonide—Dyspepsia—Paclitaxel—ovarian cancer	0.000931	0.00188	CcSEcCtD
Ciclesonide—Conjunctivitis—Epirubicin—ovarian cancer	0.000922	0.00186	CcSEcCtD
Ciclesonide—Urinary tract infection—Epirubicin—ovarian cancer	0.000922	0.00186	CcSEcCtD
Ciclesonide—Dry mouth—Docetaxel—ovarian cancer	0.000915	0.00185	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000914	0.00185	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000913	0.00184	CcSEcCtD
Ciclesonide—Fatigue—Paclitaxel—ovarian cancer	0.000912	0.00184	CcSEcCtD
Ciclesonide—Weight increased—Doxorubicin—ovarian cancer	0.000895	0.00181	CcSEcCtD
Ciclesonide—Epistaxis—Epirubicin—ovarian cancer	0.000894	0.00181	CcSEcCtD
Ciclesonide—Infection—Docetaxel—ovarian cancer	0.000891	0.0018	CcSEcCtD
Ciclesonide—Sinusitis—Epirubicin—ovarian cancer	0.00089	0.0018	CcSEcCtD
Ciclesonide—Pneumonia—Doxorubicin—ovarian cancer	0.000882	0.00178	CcSEcCtD
Ciclesonide—Infestation NOS—Doxorubicin—ovarian cancer	0.000877	0.00177	CcSEcCtD
Ciclesonide—Infestation—Doxorubicin—ovarian cancer	0.000877	0.00177	CcSEcCtD
Ciclesonide—Haemoglobin—Epirubicin—ovarian cancer	0.000855	0.00173	CcSEcCtD
Ciclesonide—Rhinitis—Epirubicin—ovarian cancer	0.000853	0.00172	CcSEcCtD
Ciclesonide—Urinary tract infection—Doxorubicin—ovarian cancer	0.000853	0.00172	CcSEcCtD
Ciclesonide—Conjunctivitis—Doxorubicin—ovarian cancer	0.000853	0.00172	CcSEcCtD
Ciclesonide—Haemorrhage—Epirubicin—ovarian cancer	0.000851	0.00172	CcSEcCtD
Ciclesonide—Pharyngitis—Epirubicin—ovarian cancer	0.000845	0.00171	CcSEcCtD
Ciclesonide—Urticaria—Paclitaxel—ovarian cancer	0.00084	0.0017	CcSEcCtD
Ciclesonide—Epistaxis—Doxorubicin—ovarian cancer	0.000827	0.00167	CcSEcCtD
Ciclesonide—Sinusitis—Doxorubicin—ovarian cancer	0.000823	0.00166	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000817	0.00165	CcSEcCtD
Ciclesonide—Dyspnoea—Docetaxel—ovarian cancer	0.000799	0.00161	CcSEcCtD
Ciclesonide—Haemoglobin—Doxorubicin—ovarian cancer	0.000792	0.0016	CcSEcCtD
Ciclesonide—Rhinitis—Doxorubicin—ovarian cancer	0.00079	0.0016	CcSEcCtD
Ciclesonide—Dyspepsia—Docetaxel—ovarian cancer	0.000789	0.00159	CcSEcCtD
Ciclesonide—Haemorrhage—Doxorubicin—ovarian cancer	0.000788	0.00159	CcSEcCtD
Ciclesonide—Pharyngitis—Doxorubicin—ovarian cancer	0.000782	0.00158	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000774	0.00156	CcSEcCtD
Ciclesonide—Fatigue—Docetaxel—ovarian cancer	0.000773	0.00156	CcSEcCtD
Ciclesonide—Immune system disorder—Epirubicin—ovarian cancer	0.000769	0.00155	CcSEcCtD
Ciclesonide—Mediastinal disorder—Epirubicin—ovarian cancer	0.000767	0.00155	CcSEcCtD
Ciclesonide—Asthenia—Paclitaxel—ovarian cancer	0.000759	0.00153	CcSEcCtD
Ciclesonide—Dysgeusia—Epirubicin—ovarian cancer	0.000726	0.00147	CcSEcCtD
Ciclesonide—Back pain—Epirubicin—ovarian cancer	0.000717	0.00145	CcSEcCtD
Ciclesonide—Immune system disorder—Doxorubicin—ovarian cancer	0.000711	0.00144	CcSEcCtD
Ciclesonide—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00071	0.00143	CcSEcCtD
Ciclesonide—Dizziness—Paclitaxel—ovarian cancer	0.000699	0.00141	CcSEcCtD
Ciclesonide—Dysgeusia—Doxorubicin—ovarian cancer	0.000671	0.00136	CcSEcCtD
Ciclesonide—Rash—Paclitaxel—ovarian cancer	0.000667	0.00135	CcSEcCtD
Ciclesonide—Dermatitis—Paclitaxel—ovarian cancer	0.000666	0.00135	CcSEcCtD
Ciclesonide—Back pain—Doxorubicin—ovarian cancer	0.000663	0.00134	CcSEcCtD
Ciclesonide—Headache—Paclitaxel—ovarian cancer	0.000663	0.00134	CcSEcCtD
Ciclesonide—Palpitations—Epirubicin—ovarian cancer	0.000655	0.00132	CcSEcCtD
Ciclesonide—Cough—Epirubicin—ovarian cancer	0.000647	0.00131	CcSEcCtD
Ciclesonide—Asthenia—Docetaxel—ovarian cancer	0.000643	0.0013	CcSEcCtD
Ciclesonide—Hypertension—Epirubicin—ovarian cancer	0.00064	0.00129	CcSEcCtD
Ciclesonide—Arthralgia—Epirubicin—ovarian cancer	0.000631	0.00127	CcSEcCtD
Ciclesonide—Chest pain—Epirubicin—ovarian cancer	0.000631	0.00127	CcSEcCtD
Ciclesonide—Nausea—Paclitaxel—ovarian cancer	0.000628	0.00127	CcSEcCtD
Ciclesonide—Dry mouth—Epirubicin—ovarian cancer	0.000617	0.00125	CcSEcCtD
Ciclesonide—Palpitations—Doxorubicin—ovarian cancer	0.000606	0.00122	CcSEcCtD
Ciclesonide—Infection—Epirubicin—ovarian cancer	0.000601	0.00121	CcSEcCtD
Ciclesonide—Cough—Doxorubicin—ovarian cancer	0.000598	0.00121	CcSEcCtD
Ciclesonide—Dizziness—Docetaxel—ovarian cancer	0.000593	0.0012	CcSEcCtD
Ciclesonide—Hypertension—Doxorubicin—ovarian cancer	0.000592	0.0012	CcSEcCtD
Ciclesonide—Arthralgia—Doxorubicin—ovarian cancer	0.000584	0.00118	CcSEcCtD
Ciclesonide—Chest pain—Doxorubicin—ovarian cancer	0.000584	0.00118	CcSEcCtD
Ciclesonide—Dry mouth—Doxorubicin—ovarian cancer	0.000571	0.00115	CcSEcCtD
Ciclesonide—Rash—Docetaxel—ovarian cancer	0.000565	0.00114	CcSEcCtD
Ciclesonide—Dermatitis—Docetaxel—ovarian cancer	0.000565	0.00114	CcSEcCtD
Ciclesonide—Headache—Docetaxel—ovarian cancer	0.000562	0.00113	CcSEcCtD
Ciclesonide—Infection—Doxorubicin—ovarian cancer	0.000556	0.00112	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000551	0.00111	CcSEcCtD
Ciclesonide—Dyspnoea—Epirubicin—ovarian cancer	0.000539	0.00109	CcSEcCtD
Ciclesonide—Nausea—Docetaxel—ovarian cancer	0.000533	0.00108	CcSEcCtD
Ciclesonide—Dyspepsia—Epirubicin—ovarian cancer	0.000532	0.00108	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000522	0.00105	CcSEcCtD
Ciclesonide—Fatigue—Epirubicin—ovarian cancer	0.000521	0.00105	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00051	0.00103	CcSEcCtD
Ciclesonide—Dyspnoea—Doxorubicin—ovarian cancer	0.000499	0.00101	CcSEcCtD
Ciclesonide—Dyspepsia—Doxorubicin—ovarian cancer	0.000493	0.000995	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000483	0.000976	CcSEcCtD
Ciclesonide—Fatigue—Doxorubicin—ovarian cancer	0.000482	0.000975	CcSEcCtD
Ciclesonide—Urticaria—Epirubicin—ovarian cancer	0.00048	0.000971	CcSEcCtD
Ciclesonide—Urticaria—Doxorubicin—ovarian cancer	0.000444	0.000898	CcSEcCtD
Ciclesonide—Asthenia—Epirubicin—ovarian cancer	0.000434	0.000877	CcSEcCtD
Ciclesonide—Asthenia—Doxorubicin—ovarian cancer	0.000401	0.000811	CcSEcCtD
Ciclesonide—Dizziness—Epirubicin—ovarian cancer	0.0004	0.000808	CcSEcCtD
Ciclesonide—Rash—Epirubicin—ovarian cancer	0.000381	0.00077	CcSEcCtD
Ciclesonide—Dermatitis—Epirubicin—ovarian cancer	0.000381	0.00077	CcSEcCtD
Ciclesonide—Headache—Epirubicin—ovarian cancer	0.000379	0.000765	CcSEcCtD
Ciclesonide—Dizziness—Doxorubicin—ovarian cancer	0.00037	0.000748	CcSEcCtD
Ciclesonide—Nausea—Epirubicin—ovarian cancer	0.000359	0.000726	CcSEcCtD
Ciclesonide—Rash—Doxorubicin—ovarian cancer	0.000353	0.000713	CcSEcCtD
Ciclesonide—Dermatitis—Doxorubicin—ovarian cancer	0.000352	0.000712	CcSEcCtD
Ciclesonide—Headache—Doxorubicin—ovarian cancer	0.000351	0.000708	CcSEcCtD
Ciclesonide—Nausea—Doxorubicin—ovarian cancer	0.000332	0.000671	CcSEcCtD
